Skip to main content

Table 1 Baseline demographics and clinical characteristics in overall population and according to type of mitral valve surgery

From: Clinical outcomes after implantation of a sutureless aortic bioprosthesis with concomitant mitral valve surgery: the SURE-AVR registry

Characteristic Overall population (n = 78) Mitral repair (n = 45) Mitral replacement (n = 33)
Women, n (%) 58 (74.4) 31 (68.9) 27 (81.8)
Age at surgery (years), mean ± SD 73.6 ± 7.6 73.0 ± 8.3 74.5 ± 6.5
 Range 55–88 55–88 60–87
Body surface area (m2), mean ± SD 1.7 ± 0.2 1.8 ± 0.2 1.7 ± 0.2
Diagnosis, n (%)
 Aortic valve stenosis 46 (59.0) 28 (62.2) 18 (54.5)
 Aortic steno-regurgitation 16 (20.5) 7 (15.6) 9 (27.3)
 Aortic regurgitation 15 (19.2) 10 (22.2) 5 (15.2)
 Mitral stenosis 7 (9.0) 3 (6.7) 4 (12.1)
 Mitral steno-regurgitation 10 (12.8) 2 (4.4) 8 (24.2)
 Mitral regurgitation 50 (64.1) 36 (80.0) 14 (42.4)
 Tricuspid regurgitation (mild to severe) 48 (61.5) 28 (62.2) 20 (60.6)
Risk factors, n (%)
 Diabetes mellitus 23 (29.5) 15 (33.3) 8 (24.2)
 Coronary artery disease 28 (35.9) 16 (35.6) 12 (36.4)
 Endocarditis 6 (7.7) 3 (6.7) 3 (9.1)
 Renal insufficiency 12 (15.4) 7 (15.6) 5 (15.2)
 Cerebrovascular events 4 (5.1) 4 (8.9) 0
 Chronic lung disease 9 (11.5) 7 (15.6) 2 (6.1)
NYHA class (n = 77) (n = 45) (n = 32)
 I 1 (1.3) 1 (2.2) 0
 II 35 (45.5) 24 (53.3) 11 (34.4)
 III 32 (41.6) 15 (33.3) 17 (53.1)
 IV 9 (11.7) 5 (11.1) 4 (12.5)
Left ventricular ejection fraction (%) (n = 25) (n = 15) (n = 10)
 Mean ± SD 53.1 ± 9.6 50.4 ± 8.8 57.0 ± 9.7
 Median (quartile 1, quartile 3) 55.0 (45.4; 60.0) 53.7 (45.0; 57.0) 57.5 (50.0; 62.0)
Logistic EuroSCORE I (n = 50) (n = 29) (n = 21)
 Mean ± SD 18.0 ± 17.5 15.9 ± 17.7 20.9 ± 17.3
 Median (quartile 1, quartile 3) 11.5 (7.5; 21.5) 9.1 (6.6; 18.5) 15.7 (9.1; 24.4)
  1. NYHA New York Heart Association, SD standard deviation